Effectiveness and safety of colistin: prospective comparative cohort study.
Paul
Mical
M
Unit of Infectious Diseases, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel. paulm@post.tau.ac.il
Bishara
Jihad
J
Levcovich
Ariela
A
Chowers
Michal
M
Goldberg
Elad
E
Singer
Pierre
P
Lev
Shaul
S
Leon
Perla
P
Raskin
Maria
M
Yahav
Dafna
D
Leibovici
Leonard
L
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D015331:Cohort Studies; D003091:Colistin / Q000009:adverse effects* / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy* / Q000401:mortality; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006090:Gram-Negative Bacteria / Q000187:drug effects / Q000302:isolation & purification; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D003091:Colistin